Home Cart 0 Sign in  

[ CAS No. 38330-80-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 38330-80-2
Chemical Structure| 38330-80-2
Structure of 38330-80-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 38330-80-2 ]

Related Doc. of [ 38330-80-2 ]

Alternatived Products of [ 38330-80-2 ]

Product Details of [ 38330-80-2 ]

CAS No. :38330-80-2 MDL No. :MFCD00014021
Formula : C4H5KO4 Boiling Point : -
Linear Structure Formula :- InChI Key :WWTULTKUWBKVGV-UHFFFAOYSA-M
M.W : 156.18 Pubchem ID :2724687
Synonyms :

Calculated chemistry of [ 38330-80-2 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.5
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 22.46
TPSA : 66.43 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.52 cm/s

Lipophilicity

Log Po/w (iLOGP) : -9.2
Log Po/w (XLOGP3) : -0.38
Log Po/w (WLOGP) : -1.7
Log Po/w (MLOGP) : -0.54
Log Po/w (SILICOS-IT) : -0.48
Consensus Log Po/w : -2.46

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.37
Solubility : 66.5 mg/ml ; 0.426 mol/l
Class : Very soluble
Log S (Ali) : -0.55
Solubility : 43.8 mg/ml ; 0.281 mol/l
Class : Very soluble
Log S (SILICOS-IT) : 0.32
Solubility : 324.0 mg/ml ; 2.07 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.57

Safety of [ 38330-80-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P305+P351+P338 UN#:N/A
Hazard Statements:H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 38330-80-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 38330-80-2 ]
  • Downstream synthetic route of [ 38330-80-2 ]

[ 38330-80-2 ] Synthesis Path-Upstream   1~17

  • 1
  • [ 38330-80-2 ]
  • [ 802294-64-0 ]
  • [ 30414-53-0 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2011, vol. 2, # 2, p. 171 - 176
  • 2
  • [ 38330-80-2 ]
  • [ 16695-14-0 ]
Reference: [1] Patent: US5912349, 1999, A,
  • 3
  • [ 38330-80-2 ]
  • [ 37517-81-0 ]
Reference: [1] Heterocycles, 1991, vol. 32, # 2, p. 245 - 251
[2] Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry, 1982, vol. 36, # 7, p. 435 - 442
[3] Analytical Chemistry, 1995, vol. 67, # 2, p. 324 - 334
[4] Journal of Agricultural and Food Chemistry, 1995, vol. 43, # 4, p. 1052 - 1056
[5] Angewandte Chemie - International Edition, 2008, vol. 47, # 52, p. 10155 - 10158
  • 4
  • [ 38330-80-2 ]
  • [ 31059-08-2 ]
  • [ 41051-15-4 ]
Reference: [1] Organic and Biomolecular Chemistry, 2009, vol. 7, # 23, p. 4960 - 4964
  • 5
  • [ 38330-80-2 ]
  • [ 109-52-4 ]
  • [ 39815-78-6 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2011, vol. 2, # 2, p. 171 - 176
  • 6
  • [ 2544-06-1 ]
  • [ 38330-80-2 ]
  • [ 62462-05-9 ]
YieldReaction ConditionsOperation in experiment
87%
Stage #1: With 1,1'-carbonyldiimidazole In acetonitrile at 20℃; for 1.5 h;
Stage #2: With magnesium chloride In acetonitrile at 20℃;
X. Methyl 5-methoxy-3-oxopentanoate CDl (3.24 g, 20.0 mmol) was added portionwise to a stirred suspension of 3-methoxypropanoic acid (1.81 mi, 19.2 mmol) in anhydrous MeCN (80 mL). The mixture was allowed to stir at rt for 1.5 hrs. A powdered mixture of magnesium chloride (1.57 g, 16.5 mmol) and methyl potassium maionate (4.5 g, 28.8 mmol) was added portionwise (note CO2 gas evolved). The mixture was allowed to stir at rt. Volatiies were removed in vacuo and hydrochloric acid (2M, 105 mL) was added. The solution was stirred at rt for 1 hr and extracted with DCM (3 x 100 mL). The organics were dried over magnesium sulfate, filtered and solvent removed in vacuo to afford methyl 5-methoxy-3-oxopentanoate (2.69 g, 87percent yield).
Reference: [1] Patent: WO2016/83816, 2016, A1, . Location in patent: Page/Page column 46
  • 7
  • [ 38330-80-2 ]
  • [ 100-39-0 ]
  • [ 52267-39-7 ]
Reference: [1] Canadian Journal of Chemistry, 2001, vol. 79, # 8, p. 1238 - 1258
  • 8
  • [ 38330-80-2 ]
  • [ 1759-53-1 ]
  • [ 32249-35-7 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2011, vol. 2, # 2, p. 171 - 176
  • 9
  • [ 108-59-8 ]
  • [ 38330-80-2 ]
YieldReaction ConditionsOperation in experiment
89% With potassium <i>tert</i>-butylate; water In ethanol at 40℃; Inert atmosphere General procedure: According to the literature procedure,10e a 250 mL, two-necked, round-bottomed flask was charged with diethyl malonate (40.0 mmol), water (40.0 mmol), and ethanol (45 mL), the mixture was stirred in 40 °C oil bath for 2 h. After that, a solution of potassium tert-butoxide (40.0 mmol) in ethanol (45 mL) was added slowly over 30 min. After completion of addition, the reaction mixture was stirred in 40 °C oil bath until consumption of the starting material (monitored by GC analysis). After removing the ethanol solvent by slow evaporation on rotary evaporator, 20 ml diethyl ether was added. The resulting solid was collected by filtration, washed sequentially with 1:1 mixture of diethyl ether and ethanol (5 mL.x.2) and diethyl ether (10 mL.x.3), transferred to a round-bottomed flask and dried under vacuum at 50 °C for 10 h to provide ethyl potassium malonate in 85percent yield.
82.8% With potassium hydroxide In methanol at 10 - 68℃; for 3.5 h; To the reaction flask was added 100 g of dimethyl malonate (0.757 mol) and 350.0 g of anhydrous methanol, and the mixture was completely mixed and dissolved, and a methanol solution of potassium hydroxide was slowly added dropwise at 10 to 35 ° C (potassium hydroxide: 42.3 G (0.754 mol), methanol: 350.0 g),Gradually there is a white solid precipitation process. After dripping,The reaction solution was further stirred at 10 to 35 ° C for about 3.5 hours.The temperature was raised to 65 to 68 ° C. The system was refluxed and filtered while hot to remove dipotassium malonate. The resulting filtrate was cooled to 0 ° C and filtered to give the monomethyl methyl malonate salt.After the filtrate was concentrated and further about 550 g of methanol was distilled off, the resulting concentrate was cooled to 0 ° C and filtered, and the resulting two partsPotassium monoglyceride potassium salt combined, vacuum drying, the final monomethyl methacrylate potassium salt 98.78g (HPLC purity:99.1percent yield: 82.80percent).
76% With potassium hydroxide In methanol Comparison Example 2
Preparation of Potassium Monomethyl Malonate (KMM)
111.6 g of KOH (1.8 mol) are dissolved in 500 g of methanol, and the solution is added to 264.2 g of dimethyl malonate (2 mol) in the course of 2 h at room temperature.
The KPG agitator is operated during this at 50 rpm.
This mixes the reaction suspension inadequately, broad edge zones remain virtually unmixed.
The reaction suspension is then filtered and the filtration residue is washed with methanol and dried in vacuo.
214.2 g of KMM are is obtained, equivalent to a yield of 76percent of theory having a DKM content of <0.2percent by weight.
65% With potassium hydroxide In methanol for 16 h; To a water-cooled solution of dimethylmalonate (132 g, 1 mol) in MeOH (500 mL) was added KOH (56 g, 1 mol) portionwise. The reaction mixture was stirred for 16 h, the solid was filtered off, and the filtrate was condensed TO-100 mL. Ether was added to precipitate out the solid, which was filtered and washed with ether, then dried to yield a white solid (102 g, 65percent).

Reference: [1] Tetrahedron, 2012, vol. 68, # 9, p. 2113 - 2120
[2] Angewandte Chemie - International Edition, 2011, vol. 50, # 19, p. 4470 - 4474
[3] Patent: CN106467492, 2017, A, . Location in patent: Paragraph 0129; 0130; 0131
[4] Journal of Physical Chemistry, 1987, vol. 91, # 19, p. 5129 - 5134
[5] Patent: US6172257, 2001, B2,
[6] Organic Syntheses, 1986, vol. 64, p. 144 - 144
[7] Canadian Journal of Chemistry, 2001, vol. 79, # 8, p. 1238 - 1258
[8] Journal of Medicinal Chemistry, 2009, vol. 52, # 4, p. 1204 - 1208
[9] Patent: WO2004/106296, 2004, A2, . Location in patent: Page 37
[10] Journal of Organic Chemistry, 1980, vol. 45, # 12, p. 2536 - 2538
[11] Heterocycles, 1991, vol. 32, # 2, p. 245 - 251
[12] Patent: US2015/210662, 2015, A1, . Location in patent: Paragraph 0070; 0071
  • 10
  • [ 67-56-1 ]
  • [ 105-53-3 ]
  • [ 38330-80-2 ]
Reference: [1] Patent: EP2221299, 2010, A2, . Location in patent: Page/Page column 8
  • 11
  • [ 98-98-6 ]
  • [ 38330-80-2 ]
  • [ 75418-74-5 ]
YieldReaction ConditionsOperation in experiment
2.48 g
Stage #1: With 1,1'-carbonyldiimidazole In tetrahydrofuran at 10 - 35℃; for 2 h; Inert atmosphere
Stage #2: With magnesium chloride In tetrahydrofuran at 10 - 35℃; Inert atmosphere
A)
methyl 3-oxo-3-(pyridin-2-yl)propanoate
To a solution of picolinic acid (3.08 g) in tetrahydrofuran (62.5 mL) was added 1,1'-carbonyldiimidazole (4.86 g) at room temperature.
The reaction mixture was stirred under an argon atmosphere at room temperature for 2 hr.
To the reaction mixture were added monomethylmonopotassium malonate (3.90 g) and magnesium chloride (2.38 g) at room temperature, and the mixture was stirred under an argon atmosphere at room temperature overnight.
The reaction mixture was neutralized with 2M hydrochloric acid, and extracted with ethyl acetate.
The organic layer was washed with saturated brine, and dried over anhydrous magnesium sulfate.
The solvent was evaporated under reduced pressure.
The residue was purified by silica gel column chromatography (ethyl acetate/hexane) to give the title compound (2.48 g).
MS (API+): [M+H]+180.1.
Reference: [1] Journal of Medicinal Chemistry, 2012, vol. 55, # 5, p. 1868 - 1897
[2] Patent: US2016/159808, 2016, A1, . Location in patent: Paragraph 1405; 1406
  • 12
  • [ 38330-80-2 ]
  • [ 100312-28-5 ]
  • [ 75418-74-5 ]
Reference: [1] Organic and Biomolecular Chemistry, 2009, vol. 7, # 23, p. 4960 - 4964
  • 13
  • [ 6089-09-4 ]
  • [ 38330-80-2 ]
  • [ 100330-50-5 ]
Reference: [1] Synthesis (Germany), 2012, vol. 44, # 13, p. 2005 - 2012
  • 14
  • [ 38330-80-2 ]
  • [ 84358-13-4 ]
  • [ 479630-08-5 ]
YieldReaction ConditionsOperation in experiment
81%
Stage #1: With 1,1'-carbonyldiimidazole In acetonitrile at 20℃; for 0.5 h;
Stage #2: With magnesium chloride In acetonitrile for 2 h; Reflux
The intermediate 12h was obtained as describe below: piperidine-1,4-dicarboxylic acid mono-tert-butyl ester (150 g, 0.655 mol) in anhydrous acetonitrile (800 ml), 1,1'-carbonyldiimidazole was added in small portions (132 g, 0.851 mol) under vigorous stirring. The resulting mixture was stirred for 30 min at ambient temperature. Then powder of mixture of anhydrous MgCl2 (62g, 0.655 mol) and methyl potassium malonate (102g, 0.655 mol) was added in portions. The resulted slurry was heated at reflux for 2 h. The reaction mixture was cooled down, diluted with mixture of ice-cold water and dichloromethane and neutralized by citric acid. The separated organic layer was washed with 5percent aqueous solution of potassium carbonate, dried over sodium sulfate and concentrated under reduced pressure. Further flash-chromatography using ethyl acetate/ hexane (1/1) gave 151 g (81percent) of intermediate 31. 4-(6-Hydroxy-2-methyl-pyrimidin-4-yl)-piperidine-1-carboxylic acid tert-butyl ester (32) [0223] Acetamidine hydrochloride (29 g, 0.3 mol) was added to the solution of sodium ethylate (0.3 mol) in anhydrous ethanol (400 ml). The mixture was stirred at ambient temperature for 10 min, and compound 31 (0.3 mol) in ethanol was added. The resulting mixture was heated at reflux for 5 h (TLC control). The reaction mixture was concentrated under reduced pressure, the remains was dissolved in water and acidified with 1N HCl to pH 5.0 and extracted with ethyl acetate (2x200 ml). The combined extracts were dried over sodium sulfate and concentrated in vacuo. The residue was purified by flash-chromatography on silica gel (eluent: n-hexane/ethyl acetate - 1/1). As a result, compound 32 (50 g, 33percent) was obtained. 4-(6-Chloro-2-methyl-pyrimidin-4-yl)-piperidine-1-carboxylic acid tert-butyl ester (12h) [0224] Intermediate 32 (50 g, 0.170 mol) and N,N-dimethylaniline (166 g, 1.365 mol) was dissolved in anhydrous toluene (1000 ml) and POCl3 (52 g, 0.34 mol) was added dropwise. The reaction mixture was heated at reflux for 3 h; then cooled down to ambient temperature and allowed to stay overnight. To this end, the mixture was poured into water; organic layer was separated, washed with 1N HCl and water. The crude product was concentrated under reduced pressure and purified with flash chromatography on silica gel (eluent: n-hexane/ethyl acetate 4/1) to provide 12h (34.3 g , 65percent).
Reference: [1] Patent: EP2719696, 2014, A1, . Location in patent: Paragraph 0221; 0222
  • 15
  • [ 38330-80-2 ]
  • [ 209995-38-0 ]
  • [ 769195-26-8 ]
YieldReaction ConditionsOperation in experiment
83%
Stage #1: With triethylamine In acetonitrile at 30 - 50℃; for 8.3 h;
Stage #2: With 1,1'-carbonyldiimidazole In acetonitrile at 30℃; for 3.5 h;
Step-1: Preparation of Methyl 4-(2,4,5-trifluorophenyl)-3-oxobutanoate (Formula III)Monomethylmalonate potassium salt (MMMKS; 122.8 g), triethylamine (264 ml) and acetonitrile (1200 ml) were charged to a 3L round bottom flask (RBF) fitted with condenser, nitrogen inlet, thermometer pocket and overhead stirrer. MgCl2 (65.2 g) was added lot- wise to the above mixture over a period of 15-20 min at 30°C and the mixture was stirred for 10 min. The reaction mixture was heated to 50°C for 8 h at same temperature. After 8 hours, the reaction mixture was cooled to 30°C and marked as Part A. Ι, -carbonyldiimidazole (CDI) (1 10 g) and acetonitrile (250 ml) were charged to a 2L RBF fitted with nitrogen inlet, thermometer pocket, addition funnel and overhead stirrer. To this, a solution of 2,4,5-trifluorophenyl acetic acid (100 g) in acetonitrile (600 ml) was added slowly over a period of a 30 min at 30 °C and the reaction mixture was stirred at 30 °C for 3 h. This solution was marked as part B.The Part B solution was added drop-wise to part-A slurry over a period of 2 hour at 30 °C and the mixture was stirred. The progress of the reaction was monitored by TLC (Mobile phase: n-Hexane: ethyl acetate; 50:50). After 12 h, TLC analysis indicated <5percent of un-reacted starting material. The reaction mixture was concentrated under reduced pressure at 50-55°C to get a thick slurry. To this, water (1000 ml) was added and the mixture was cooled to 10-15°C and cone. HC1 (220.6 ml) was added slowly, below 20°C. MTBE (700 ml) was added to the mixture and the mixture was stirred for 30 min. The layers were separated and the aqueous layer was extracted with MTBE (200 ml). The combined organic layers were washed with 7 percent aqueous NaHC03 solution (400 ml) followed by washing with brine (200 ml). The organic layer was dried over sodium sulphate and concentrated under vacuum at 50°C to get an oil (120 g). The obtained oil was diluted with isopropyl alcohol (400 ml) and cooled to 20°C. To this water (800 ml) was added slowly over a period of 4 hours at 18-20°C. The slurry was then stirred for 4 hours and filtered. The obtained cake was washed with water (100 ml) and then suck dried to obtain free solid of titled product.Yield: 115 g (83 percent); m.p.: 37-39°C; HPLC Purity : > 95 percent.H NMR (CDCI3): 3.64 (s, 3H), 3.75 (s, 2H), 3.85 (s, 2H), 6.88-7.11 (m, 2H).Mass spectrum: 247 [M+l] +.
83%
Stage #1: With triethylamine; magnesium chloride In acetonitrile at 30 - 50℃; Inert atmosphere
Stage #2: With 1,1'-carbonyldiimidazole In acetonitrile at 30℃; for 5.5 h; Inert atmosphere
Example 1 Step-1 Preparation of Methyl 4-(2,4,5-trifluorophenyl)-3-oxobutanoate (Formula III) [0156] Monomethylmalonate potassium salt (MMMKS; 122.8 g), triethylamine (264 ml) and acetonitrile (1200 ml) were charged to a 3 L round bottom flask (RBF) fitted with condenser, nitrogen inlet, thermometer pocket and overhead stirrer. MgCl2 (65.2 g) was added lot-wise to the above mixture over a period of 15-20 min at 30° C. and the mixture was stirred for 10 min. The reaction mixture was heated to 50° C. for 8 h at same temperature. After 8 hours, the reaction mixture was cooled to 30° C. and marked as Part A. 1,1′-carbonyldiimidazole (CDI) (110 g) and acetonitrile (250 ml) were charged to a 2 L RBF fitted with nitrogen inlet, thermometer pocket, addition funnel and overhead stirrer. To this, a solution of 2,4,5-trifluorophenyl acetic acid (100 g) in acetonitrile (600 ml) was added slowly over a period of a 30 min at 30° C. and the reaction mixture was stirred at 30° C. for 3 h. This solution was marked as part B. [0157] The Part B solution was added drop-wise to part-A slurry over a period of 2 hour at 30° C. and the mixture was stirred. The progress of the reaction was monitored by TLC (Mobile phase: n-Hexane: ethyl acetate; 50:50). After 12 h, TLC analysis indicated <5percent of un-reacted starting material. The reaction mixture was concentrated under reduced pressure at 50-55° C. to get a thick slurry. To this, water (1000 ml) was added and the mixture was cooled to 10-15° C. and conc. HCl (220.6 ml) was added slowly, below 20° C. MTBE (700 ml) was added to the mixture and the mixture was stirred for 30 min. The layers were separated and the aqueous layer was extracted with MTBE (200 ml). The combined organic layers were washed with 7percent aqueous NaHCO3 solution (400 ml) followed by washing with brine (200 ml). The organic layer was dried over sodium sulphate and concentrated under vacuum at 50° C. to get an oil (120 g). The obtained oil was diluted with isopropyl alcohol (400 ml) and cooled to 20° C. To this water (800 ml) was added slowly over a period of 4 hours at 18-20° C. The slurry was then stirred for 4 hours and filtered. The obtained cake was washed with water (100 ml) and then suck dried to obtain free solid of titled product. [0158] Yield: 115 g (83percent); m.p.: 37-39° C.; HPLC Purity: ≧95percent. [0159] 1H NMR (CDCl3): 3.64 (s, 3H), 3.75 (s, 2H), 3.85 (s, 2H), 6.88-7.11 (m, 2H). [0160] Mass spectrum: 247[M+1]+.
Reference: [1] Tetrahedron Asymmetry, 2006, vol. 17, # 2, p. 205 - 209
[2] Patent: WO2012/25944, 2012, A2, . Location in patent: Page/Page column 29-30
[3] Patent: US2013/158265, 2013, A1, . Location in patent: Paragraph 0156; 0157; 0158; 0159; 0160
  • 16
  • [ 38330-80-2 ]
  • [ 209995-38-0 ]
  • [ 769195-26-8 ]
Reference: [1] Tetrahedron Asymmetry, 2006, vol. 17, # 2, p. 205 - 209
  • 17
  • [ 38330-80-2 ]
  • [ 7154-66-7 ]
  • [ 294881-08-6 ]
Reference: [1] Chemical Communications, 2013, vol. 49, # 46, p. 5313 - 5315
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 38330-80-2 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 16695-14-0

[ 16695-14-0 ]

Methyl hydrogen malonate

Similarity: 0.95

Chemical Structure| 6148-64-7

[ 6148-64-7 ]

Potassium 3-ethoxy-3-oxopropanoate

Similarity: 0.91

Chemical Structure| 6149-41-3

[ 6149-41-3 ]

Methyl 3-hydroxypropanoate

Similarity: 0.90

Chemical Structure| 1071-46-1

[ 1071-46-1 ]

3-Ethoxy-3-oxopropanoic acid

Similarity: 0.87

Chemical Structure| 105-53-3

[ 105-53-3 ]

Diethyl malonate

Similarity: 0.87

Esters

Chemical Structure| 16695-14-0

[ 16695-14-0 ]

Methyl hydrogen malonate

Similarity: 0.95

Chemical Structure| 6148-64-7

[ 6148-64-7 ]

Potassium 3-ethoxy-3-oxopropanoate

Similarity: 0.91

Chemical Structure| 6149-41-3

[ 6149-41-3 ]

Methyl 3-hydroxypropanoate

Similarity: 0.90

Chemical Structure| 1071-46-1

[ 1071-46-1 ]

3-Ethoxy-3-oxopropanoic acid

Similarity: 0.87

Chemical Structure| 105-53-3

[ 105-53-3 ]

Diethyl malonate

Similarity: 0.87

Carboxylic Acid Salts

Chemical Structure| 6148-64-7

[ 6148-64-7 ]

Potassium 3-ethoxy-3-oxopropanoate

Similarity: 0.91

Chemical Structure| 51877-54-4

[ 51877-54-4 ]

Potassium oxirane-2-carboxylate

Similarity: 0.59

Chemical Structure| 6100-18-1

[ 6100-18-1 ]

Potassium succinate trihydrate

Similarity: 0.54

Chemical Structure| 17378-36-8

[ 17378-36-8 ]

Potassium heptadecanoate

Similarity: 0.52

Chemical Structure| 19455-23-3

[ 19455-23-3 ]

Potassium pivalate

Similarity: 0.52